Status: current, Primitive. Date: 30-Jun 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 58401000168111 | Candesartan/HCT 16 mg/12.5 mg (Sandoz) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 58411000168114 | Candesartan/HCT 16 mg/12.5 mg (Sandoz) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Candesartan/HCT 16 mg/12.5 mg (Sandoz) | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Candesartan/HCT 16 mg/12.5 mg (Sandoz) tablet | Is a | True | Candesartan/HCT 16 mg/12.5 mg (Sandoz) | Inferred relationship | Some | |
| Candesartan/HCT 16 mg/12.5 mg (Sandoz) tablet, 30 | has TP | True | Candesartan/HCT 16 mg/12.5 mg (Sandoz) | Inferred relationship | Some | |
| Candesartan/HCT 16 mg/12.5 mg (Sandoz) tablet, 30, blister pack | has TP | True | Candesartan/HCT 16 mg/12.5 mg (Sandoz) | Inferred relationship | Some | |
| Candesartan/HCT 16 mg/12.5 mg (Sandoz) (candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg) tablet, 30 tablets, bottle (containered trade product pack) | has TP | True | Candesartan/HCT 16 mg/12.5 mg (Sandoz) | Inferred relationship | Some |
Reference Sets
FHIR